The small trial will help to establish whether kidneys from genetically modified pigs can be transplanted into people safely and effectively.

Learn more about whether Avidity Biosciences, Inc. or TG Therapeutics, Inc. is a better investment based on AAII's A+ ...

A biotechnology company making headlines for its work in organ transplantation is planning to construct an estimated $96 million facility in northeast Houston to breed genetically engineered animals, ...

SEOUL, Jan. 22 (UPI) --North Korea defended its right to maintain a nuclear weapons program at a United Nations disarmament conference in Geneva on Tuesday, shortly after U.S. President Donald ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that five posters across its ...

View United Therapeutics Corporation (UTHR) current and estimated P/E ratio data provided by Seeking Alpha.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

If you’re on the fence about investing in United Therapeutics Corporation, Natera or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making ...

United Therapeutics is a biotech company focused on the development of therapies for the treatment of pulmonary arterial hypertension. The USA-based company has five approved products on the market ...